The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Osimertinib then chemotherapy in EGFR-mutated lung cancer with osimertinib third-line rechallenge (OCELOT).
 
Daniel Adam Breadner
Stock and Other Ownership Interests - Need
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Takeda
Speakers' Bureau - Amgen; AstraZeneca Canada; Bayer; Merck
 
Mark David Vincent
Leadership - Aptose Biosciences
Stock and Other Ownership Interests - Aptose Biosciences
Honoraria - Amgen; ApoBiologix; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Lilly; Merck; Novartis; Roche Canada; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; Novartis; Roche
Speakers' Bureau - AstraZeneca; Lilly
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - CEO Sarissa Inc., and patent holder of two non-commercialized patents
 
Geoffrey Liu
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Jazz Pharmaceuticals; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Pfizer; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim; roche (Inst); Takeda
 
Jeffrey Rothenstein
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer; Roche Canada
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Roche Canada; Takeda
 
Ines B. Menjak
Honoraria - Bristol-Myers Squibb/Roche
Consulting or Advisory Role - Amgen; AstraZeneca Canada; AstraZeneca Canada
Other Relationship - AstraZeneca; Bristol-Myers Squibb/Roche; Bristol-Myers Squibb/Roche; Takeda
 
Parneet Kaur Cheema
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Janssen Oncology; Merck
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol Myers Squibb; Janssen Oncology; Merck; Novartis; Novartis; Pfizer; Roche
 
Rosalyn A. Juergens
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Merck Sharp & Dohme; Mirati Therapeutics; Novartis Canada Pharmaceuticals Inc; Roche Canada; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Fusion Pharmaceuticals; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche Canada; Sanofi/Regeneron; Takeda
Research Funding - Alkermes (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Fusion Pharmaceuticals (Inst); Janssen (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
 
Hamid Mithoowani
No Relationships to Disclose
 
Puneet Bains
Travel, Accommodations, Expenses - Eisai
 
Ying Wang
Honoraria - AstraZeneca Canada; Merck; Takeda
Research Funding - AstraZeneca (Inst); Roche (Inst)
 
Paul Wheatley-Price
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Jazz Pharmaceuticals; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche Canada (Inst)